B cell tolerance to xenoantigens

Xenotransplantation

Volumn 10, Issue 2, 2003, Pages 98-106

  Ohdan, Hideki ^a   Sykes, Megan ^b  

^a HIROSHIMA UNIVERSITY   (Japan)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

1,3Gal; B cells; Bone marrow transplantation; Gal; Tolerance; Xenotransplantation

Indexed keywords

ANTIBODY; ANTIGEN; COMPLEMENT REGULATORY PROTEIN; EPITOPE; GALACTOSYLGALACTOSE; HETEROANTIGEN; PROTEIN; UNCLASSIFIED DRUG;

ACUTE VASCULAR REJECTION; ANIMAL CELL; ANTIBODY RESPONSE; ANTIGEN ANTIBODY REACTION; ANTIGEN RECOGNITION; B CELL TOLERANCE; B LYMPHOCYTE; CHIMERA; COMPLEMENT INHIBITION; CONTROLLED STUDY; EXTRACORPOREAL CIRCULATION; HYPERACUTE GRAFT REJECTION; IMMUNOADSORPTION; IMMUNOLOGICAL TOLERANCE; MOUSE; NONHUMAN; ORGAN DONOR; ORGAN DONOR SHORTAGE; PHENOTYPE; PLASMA CELL; PRIORITY JOURNAL; REVIEW; SWINE; TRANSGENIC ANIMAL; VASCULAR ENDOTHELIUM; XENORECOGNITION; XENOTRANSPLANTATION;

ANIMALS; ANTIGENS, HETEROPHILE; B-LYMPHOCYTES; HUMANS; IMMUNE TOLERANCE; TRANSPLANTATION, HETEROLOGOUS;

EID: 0043027756     PISSN: 0908665X     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-3089.2003.02108.x     Document Type: Review

References (75)

1. SACHS DH. The pig as a xenograft donor. Pathol Biol (Paris) 1994; 42: 217.
2. GALILI U, SHOHET SB, KOBRIN E et al. Man, apes, and Old World monkeys differ from other mammals in the expression of α-galactosyl epitopes on nucleated cells. J Biol Chem 1988; 263: 17755.
3. GOOD AH, COOPER DKC, MALCOLM AJ et al. Identification of carbohydrate structures that bind human antiporcine antibodies: implications for discordant xenografting in humans. Transplant Proc 1992; 24: 559.
4. ORIOL R, YE Y, KOREN E, COOPER DKC. Carbohydrate antigens of pig tissues reacting with human natural antibodies as potential targets for hyperacute vascular rejection in pig-to-man organ xenotransplantation. Transplantation 1993; 56: 1433.
5. GALILI U. Interaction of the natural anti-Gal antibody with α-galactosyl epitopes: a major obstacle for xenotransplantation in humans. Immunol Today 1993; 14: 480.
6. SANDRIN MS, VAUGHAN HA, DABKOWSKI PL, MCKENZIE IFC. Anti-pig IgM antibodies in human serum react predominantly with Galα1-3Gal epitopes. Proc Natl Acad Sci USA 1993; 90: 11391.
7. LEVENTHAL JR, DALMASSO AP, CROMWELL JW et al. Prolongation of cardiac xenograft survival by depletion of complement. Transplantation 1993; 55: 857.
8. COZZI E, WHITE D. The generation of transgenic pigs as potential organ donors for humans. Nat Med 1995; 1: 964.
9. TANIGUCHI S, NEETHLING FA, KORCHAGINA EY et al. In vivo immunoadsorption of antipig antibodies in baboons using a specific Gal α1-3Gal column. Transplantation 1996; 62: 1379.
10. SIMON PM, NEETHLING FA, TANIGUCHI S et al. Intravenous infusion of Gal α1Gal oligosaccharides in baboons delays hyperacute rejection of porcine heart xenografts. Transplantation 1998; 65: 346.
11. PLATT JL, LIN SS, MCGREGOR CG. Acute vascular rejection. Xenotransplantation 1998; 5: 169.
12. COOPER DKC. Xenoantigens and xenoantibodies. Xenotransplantation 1998; 5: 6.
13. PALMETSHOFER A, GALILI U, DALMASSO AP et al. α-galactosyl epitope-mediated activation of porcine aortic endothelial cells: type II activation. Transplantation 1998; 65: 971.
14. COOPER DKC, KOREN E, ORIOL R. Oligosaccharides and discordant xenotransplantation. Immunol Rev 1994; 141: 31.
15. MACCHIARINI P, ORIOL R, AZIMZADEH A et al. Evidence of human non-α-galactosyl antibodies involved in the hyperacute rejection of pig lungs and their removal by pig organ perfusion. J Thorac Cardiovasc Surg 1998; 116: 831.
16. BOUHOURS D, LIAIGRE J, NAULET J et al. A novel glycosphingolipid expressed in pig kidney: Gal α1-3Lewis (x) hexaglycosylceramide. Glycoconj J 1997; 14: 29.
17. BOUHOURS D, LIAIGRE J, LEMOINE J et al. Two novel isoneolacto-undecaglycosylceramides carrying Gal α1-3Lewis (x) on the 6-linked antenna and N-acetylneuraminic acid α2 (r) 3 or Galactose α1 (r) 3 on the 3-linked antenna, expressed in porcine kidney. Glycoconj J 1998; 15: 1001.
18. ZHU A. Binding of human natural antibodies to non αGal xenoantigens on porcine erythrocytes. Transplantation 2000; 69: 2422.
19. +) B cells? Immunol Today 1989; 10: 334.
20. PARKER W, BRUNO D, HOLZKNECHT ZE, PLATT JL. Characterization and affinity isolation of xenoreactive human natural antibodies. J Immunol 1994; 153: 3791.
21. MCMORROW IM, COMRACK CA, SACHS DH, DERSIMONIAN H. Heterogeneity of human anti-pig natural antibodies cross-reactive with the Galα1,3Galactose epitope. Transplantation 1997; 64: 501.
22. Yu PB, PARKER W, EVERETT ML et al. Immunochemical properties of anti-Galα1-3Gal antibodies after sensitization with xenogeneic tissues. J Clin Immunol 1999; 19: 116.
23. AUCHINCLOSS H Jr, SACHS DH. Xenogeneic transplantation. Annu Rev Immunol 1998; 16: 433.
24. CHEN X, MARTIN F, FORBUSH KA et al. Evidence for selection of a population of multi-reactive B cells into the splenic marginal zone. Int Immunol 1997; 9: 27.
25. THALL AD, MALY P, LOWE JB. Oocyte Gal α1,3Gal epitopes implicated in sperm adhesion to the zona pellucida glycoprotein ZP3 are not required for fertilization in the mouse. J Biol Chem 1995; 270: 21437.
26. THALL AD, MURPHY HS, LOWE JB. α1,3-Galactosyltransferase-deficient mice produce naturally occurring cytotoxic anti-Gal antibodies. Transplant Proc 1996; 28: 556.
27. OHDAN H, SWENSON KG, KRUGER GRAY HS et al. Mac1-negative B-1b phenotype of natural antibody-producing cells, including those responding to Gal α1-3Gal epitopes in α1,3-galactosyltransferase-deficient mice. J Immunol 2000; 165: 5518.
28. + B-lymphocytes. Transplant Proc 1996; 28: 545.
29. VINK A, WARNIER G, BROMBACHER F, RENAULD JC. Interleukin 9-induced in vivo expansion of the B-1 lymphocyte population. J Exp Med 1999; 189: 1413.
30. KANTOR AB, MERRILL CE, HERZENBERG LA, HILLSON JL. An unbiased analysis of V (H) -D-J (H) sequences from B-1a, B-1b, and conventional B cells. J Immunol 1997; 158: 1175.
31. TANEMURA M, YIN D, CHONG AS, GALILI U. Differential immune responses to α-Gal epitopes on xenografts and allografts: implications for accommodation in xenotransplantation. J Clin Invest 2000; 105: 301.
32. OHDAN H, SWENSON KG, KITAMURA H et al. Tolerization of Gal α1,3Gal-reactive B cells in pre-sensitized α1,3-galactosyltransferase-deficient mice by nonmyeloablative induction of mixed chimerism. Xenotransplantation 2001; 8: 227.
33. PEETERS CC, TENBERGEN-MEEKES AM, POOLMAN JT et al. Effect of carrier priming on immunogenicity of saccharide-protein conjugate vaccines. Infect Immun 1991; 59: 3504.
34. SEPPALA I, PELKONEN J, MAKELA O. Isotypes of antibodies induced by plain dextran or a dextran-protein conjugate. Eur J Immunol 1985; 15: 827.
35. CRETIN N, BRACY J, HANSON K, IACOMINI J. The role of T cell help in the production of antibodies specific for Gal α1-3Gal. J Immunol 2002; 168: 1479.
36. OHDAN H, YANG YG, SWENSON KG et al. In vivo T-cell depletion enhances production of anti-Gal α1,3Gal natural antibodies in α1,3-galactosyltransferase-deficient mice. Transplantation 2000; 69: 910.
37. LAI L, KOLBER-SIMONDS D, PARK KW et al. Production of α-1,3-galactosyltransferase knockout pigs by nuclear transfer cloning. Science 2002; 295: 1089.
38. LIN Y, GOEBELS J, XIA G et al. Induction of specific transplantation tolerance across xenogeneic barriers in the T-independent immune compartment. Nat Med 1998; 4: 173.
39. LIN Y, SOARES MP, SATO K et al. Accommodated xenografts survive in the presence of anti-donor antibodies and complement that precipitate rejection of naive xenografts. J Immunol 1999; 163: 2850.
40. LATEMPLE DC, GALILI U. Adult and neonatal anti-Gal response in knock-out mice for α1,3galactosyltransferase. Xenotransplantation 1998; 5: 191.
41. NIKOLIC B, COOKE DT, ZHAO G, SYKES M. Both gamma delta T cells and NK cells inhibit the engraftment of xenogeneic rat bone marrow cells and the induction of xenograft tolerance in mice. J Immunol 2001; 166: 1398.
42. SHARABI Y, AKSENTIJEVICH I, SUNDT TM III et al. Specific tolerance induction across a xenogeneic barrier: production of mixed rat/mouse lymphohematopoietic chimeras using a nonlethal preparative regimen. J Exp Med 1990; 172: 195.
43. LEE LA, SERGIO JJ, SYKES M. Evidence for non-immune mechanisms in the loss of hematopoietic chimerism in rat/mouse mixed xenogeneic chimeras. Xenotransplantation 1995; 2: 57.
44. TOMITA Y, LEE LA, SYKES M. Engraftment of rat bone marrow and its role in negative selection of murine T cells in mice conditioned with a modified non-myeloablative regimen. Xenotransplantation 1994; 1: 109.
45. NIKOLIC B, LEI H, PEARSON DA et al. Role of intrathymic rat class II+ cells in maintaining deletional tolerance in xenogeneic rat/mouse bone marrow chimeras. Transplantation 1998; 65: 1216.
46. AKSENTIJEVICH I, SACHS DH, SYKES M. Humoral tolerance in xenogeneic BMT recipients conditioned by a non-myeloablative regimen. Transplantation 1992; 53: 1108.
47. LEE LA, SERGIO JJ, SACHS DH, SYKES M. Mechanism of tolerance in mixed xenogeneic chimeras prepared with a non-myeloablative conditioning regimen. Transplant Proc 1994; 26: 1197.
48. YANG YG, DEGOMA E, OHDAN H et al. Tolerization of anti-Gal α1-3Gal natural antibody-forming B cells by induction of mixed chimerism. J Exp Med 1998; 187: 1335.
49. OHDAN H, YANG YG, SHIMIZU A et al. Mixed chimerism induced without lethal conditioning prevents T cell- and anti-Galα1,3Gal-mediated graft rejection. J Clin Invest 1999; 104: 281.
50. OHDAN H, YANG YG, SWENSON KG et al. T cell and B cell tolerance to Gal α1,3Gal-expressing heart xenografts is achieved in α1,3-galactosyltransferase-deficient mice by nonmyeloablative induction of mixed chimerism. Transplantation 2001; 71: 1532.
51. BUHLER L, AWWAD M, BASKER M et al. High-dose porcine hematopoietic cell transplantation combined with CD40 ligand blockade in baboons prevents an induced anti-pig humoral response. Transplantation 2000; 69: 2296.
52. GRITSCH HA, GLASER RM, EMERY DW et al. The importance of nonimmune factors in reconstitution by discordant xenogeneic hematopoietic cells. Transplantation 1994; 57: 906.
53. YANG YG, SERGIO JJ, SWENSON K et al. Donor-specific growth factors promote swine hematopoiesis in SCID mice. Xenotransplantation 1996; 3: 92.
54. SABLINSKI T, GIANELLO PR, BAILIN M et al. Pig to monkey bone marrow and kidney xenotransplantation. Surgery 1997; 121: 381.
55. KOZLOWSKI T, MONROY R, GIOVINO M et al. Effect of pig-specific cytokines on mobilization of hematopoietic progenitor cells in pigs and on pig bone marrow engraftment in baboons. Xenotransplantation 1999; 6: 17.
56. APPEL JZ III, ALWAYN IP, BUHLER L et al. Modulation of platelet aggregation in baboons: implications for mixed chimerism in xenotransplantation. 1. The roles of individual components of a transplantation conditioning regimen and of pig peripheral blood progenitor cells. Transplantation 2001; 72: 1299.
57. APPEL JZ, 3RD ALWAYN IP, CORREA LE et al. Modulation of platelet aggregation in baboons: implications for mixed chimerism in xenotransplantation. II. The effects of cyclophosphamide on pig peripheral blood progenitor cell-induced aggregation. Transplantation 2001; 72: 1306.
58. BRACY JL, SACHS DH, IACOMINI J. Inhibition of xenoreactive natural antibody production by retroviral gene therapy. Science 1998; 281: 1845.
59. BRACY JL, IACOMINI J. Induction of B-cell tolerance by retroviral gene therapy. Blood 2000; 96: 3008.
60. BRACY JL, CRETIN N, COOPER DKC, IACOMINI J. Xenoreactive natural antibodies. Cell Mol Life Sci 1999; 56: 1001.
61. ANDERSON RE, WARNER NL. Radiosensitivity of T and B lymphocytes. III. Effect of radiation on immunoglobulin production by B cells. J Immunol 1975; 115: 161.
62. SLIFKA MK, ANTIA R, WHITMIRE JK, AHMED R. Humoral immunity due to long-lived plasma cells. Immunity 1998; 8: 363.
63. KLINMAN NR, The 'clonal selection hypothesis' and current concepts of B cell tolerance. Immunity 1996; 5: 189.
64. MURAKAMI M, TSUBATA T, OKAMOTO M et al. Antigen-induced apoptotic death of Ly-1 B cells responsible for autoimmune disease in transgenic mice. Nature 1992; 357: 77.
65. RUSSELL DM, DEMBIC Z, MORAHAN G et al. Peripheral deletion of self-reactive B cells. Nature 1991; 354: 308.
66. NEMAZEE D, BUERKI K. Clonal deletion of autoreactive B lymphocytes in bone marrow chimeras. Proc Natl Acad Sci U S A 1989; 86: 8039.
67. HARTLEY SB, CROSBIE J, BRINK R et al. Elimination from peripheral lymphoid tissues of self-reactive B lymphocytes recognizing membrane-bound antigens. Nature 1991; 353: 765.
68. TIEGS SL, RUSSELL DM, NEMAZEE D. Receptor editing in self-reactive bone marrow B cells. J Exp Med 1993; 177: 1009.
69. - bone marrow B cells in vitro. Immunity 1997; 6: 429.
70. PELANDA R, SCHWERS S, SONODA E et al. Receptor editing in a transgenic mouse model: site, efficiency, and role in B cell tolerance and antibody diversification. Immunity 1997; 7: 765.
71. GOODNOW CC, CROSBIE J, ADELSTEIN S et al. Altered immunoglobulin expression and functional silencing of self-reactive B lymphocytes in transgenic mice. Nature 1988; 334: 676.
72. NOSSAL GJ. Clonal anergy of B cells: a flexible, reversible, and quantitative concept. J Exp Med 1996; 183: 1953.
73. MAGEE JC, COLLINS BH, HARLAND RC et al. Immunoglobulin prevents complement-mediated hyperacute rejection in swine-to-primate xenotransplantation. J Clin Invest 1995; 96: 2404.
74. SCHREIBER JR, COOPER LJ, DIEHN S et al. Variable region-identical monoclonal antibodies of different IgG subclass directed to Pseudomonas aeruginosa lipopolysaccharide O-specific side chain function differently. J Infect Dis 1993; 167: 221.
75. WEISS RA. Transgenic pigs and virus adaptation. Nature 1998; 391: 327.